Drug Profile
Ciliary neurotrophic factor implant - Microbot Medical
Alternative Names: Ciliary neurotrophic factor implant -; CNTF implant -Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator StemCells; University of Lausanne
- Developer StemCells
- Class Eye disorder therapies; Obesity therapies
- Mechanism of Action Ciliary neurotrophic factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis
Most Recent Events
- 28 Nov 2016 StemCells has been acquired by Microbot Medical
- 24 May 2000 Discontinued-I for Amyotrophic lateral sclerosis in USA (Intracranial)
- 28 Jan 1998 New profile